Pre-Eclampsia; Mild

2

Review clinical trials related to Pre-Eclampsia; Mild. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Low-Sodium Diet for Postpartum Blood Pressure Control

The goal of this randomized controlled trial is to learn if a low-sodium diet improves postpartum blood pressure control in adults who were diagnosed with a late-onset hypertensive disorder of pregnancy. The main questions it aims to answer are: * Does a low-sodium diet lead to decreased mean arterial blood pressure (MAP) on postpartum day 7? * Does a low-sodium diet lead to a decreased MAP on postpartum day 3? * Does a low-sodium diet reduce 30-day hospital readmissions for hypertension-related indications? Participants will be provided with meals for 7 days following their delivery. The experimental diet will contain less than 2000mg of sodium daily. The control diet will have variable sodium content with no restrictions. Participants will be asked to record the food they consume over the study week. They will also be provided with a blood pressure (BP) cuff and asked to record their BP at least once daily.

Participants needed: 110
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Women and Infants Hospital of Rhode IslandUpdated: Aug 12, 2026
Eligibility criteria

Adults > 18 years of age [+4]

Multiple gestations [+3]

Status: Recruiting

PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)

The aim of this prospective observational cohort study is to investigate the pathophysiological mechanisms behind and risk of pre-eclampsia in women pregnant after fertility treatment with oocyte donation. The participants are included in of of two cohorts. One includes women pregnant after oocyte donation whereas the other includes women pregnant after IVF treatment with autologous oocytes. Participants will be followed throughout pregnancy with blood samples, blood pressure, clinical controls and ultrasound examinations. Clinical outcomes will be registered post-partum.

Participants needed: 462
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Copenhagen University Hospital, HvidovreUpdated: Apr 13, 2026Locations: 6
Eligibility criteria

Age > 18 years [+4]

Age < 18 years [+17]